SCHEMBL28840211

SCHEMBL28840211

O=Cc1cncc(-c2ccc(OC(F)(F)C(F)(F)F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIP4K2A P48426 1/20 0.46
SCN10A Q9Y5Y9 1/20 0.39
PRMT6 Q96LA8 1/20 0.38
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
DRD1 P21728 2/20 0.36
PIP4K2B P78356 2/20 0.36
ABL1 P00519 5/20 0.36
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
PTGS2 P35354 2/20 0.34
KIF11 P52732 1/20 0.34
MAP4K4 O95819 1/20 0.34
OPRM1 P35372 1/20 0.34
KCNH2 Q12809 1/20 0.34
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9607437 0.88 PIP4K2A (0.57) PIP4K2ASCN10APRMT6CYP11B1CYP11B2
SCHEMBL28104718 0.86 PIP4K2A (0.46) PIP4K2ASCN10APRMT6CYP11B1CYP11B2
SCHEMBL1230329 0.79 PIP4K2A (0.51) PIP4K2ASCN10APRMT6CYP11B1CYP11B2
SCHEMBL29066290 0.77 PIP4K2B (0.54) PIP4K2ACYP11B1CYP11B2PIP4K2BCA12
SCHEMBL2318682 0.77 MAP4K4 (0.55) CYP11B1CYP11B2MAP4K4
SCHEMBL17103331 0.76 ALDH1A1 (0.48) DRD1KIF11
SCHEMBL27995027 0.75 CYP11B2 (0.55) SCN10ACYP11B1CYP11B2ABL1MAP4K4
SCHEMBL1582492 0.75 PIP4K2B (0.51) SCN10ACYP11B1CYP11B2PIP4K2BPTGS2
SCHEMBL29598147 0.75 PIP4K2B (0.51) SCN10ACYP11B1CYP11B2PIP4K2BPTGS2
SCHEMBL31180051 0.74 PTGS2 (0.38) PIP4K2APIP4K2BPTGS2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104379574-B For suppressing the heterocyclic carbamate derivatives of the activity of ABL1, ABL2 and BCR ABL1 诺华股份有限公司 2017-03-01 CN disclosed